Navigate to Other Instruments
AZNAstraZeneca PLCAstraZeneca PLC
AZNKey Takeaways
Last updated: 2026-07-27- •AZN Q2 core EPS of $2.15–$2.63 beat consensus by 8–99% depending on measure, with revenue of $14.46–$15.38B exceeding forecasts — a confirmed, material earnings beat.
- •Leverage takeaway: A 50x long AZN CFD at the 24h low of $164.39 yields ~215% margin return at $171.40; shorts above 27x face liquidation risk if price revisits $177.78.
- •FTSE 100 and STOXX Europe 600 see mild bullish index-level support from AZN's weighting; European pharma peers including GSK benefit from positive sector sentiment read-through.
- •FY26 guidance reaffirmed — low double-digit EPS growth and mid-to-high single-digit revenue growth — supports a multi-year quality-growth re-rating thesis.
- •Primary downside risk: Farxiga U.S. patent expiry headwinds and any oncology trial failures could reverse the bullish narrative; post-earnings IV compression may limit further options premium.
Price & Market Structure
Trading Regime Status
Latest Pulses
AstraZeneca Q2 Earnings Beat: EPS Surges 18–25%, Dividend Raised, FY26 Guidance Reaffirmed — Leverage Impact & Cross-Market Analysis
AstraZeneca PLC (AZN) reported a strong Q2 earnings beat, with core EPS rising approximately 18–25% year-over-year depending on reporting basis. According to Investing.com, core EPS came in at $2.63 v
Royalty Pharma Pays Up to $425M for AstraZeneca's Cliramitug Royalty — What It Means for RPRX and AZN
Royalty Pharma plc (RPRX) has agreed to acquire a portion of Neurimmune's royalty interest in AstraZeneca's cliramitug for up to $425 million, according to Business Insider Markets. The deal comprises
AstraZeneca in $15B Talks for Ivonescimab — The Lung Cancer Deal That Could Reshape Oncology
As reported by Bloomberg and Reuters, AstraZeneca Plc is in discussions with Summit Therapeutics Inc. over a potential licensing agreement for ivonescimab, an experimental lung cancer drug, in a deal
AstraZeneca's $600M Zegfrovy Bet: What the Unverified Deal Means for Oncology Traders
Reports are circulating that AstraZeneca (AZN) has licensed Zegfrovy (sunvozertinib) — a lung cancer drug targeting EGFR exon 20 insertion mutations in non-small cell lung cancer (NSCLC) — for a $600
Get Started with AstraZeneca PLC
Start trading AstraZeneca PLC on CoinUnited.io with industry-leading leverage and zero fees.
Trade with Leverage
Trade AZN CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Zero trading fees
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade AstraZeneca PLC: Step-by-Step Guide
Learn how to trade AstraZeneca PLC (AZN) on CoinUnited.io with up to 1000x leverage and zero trading fees. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find AZN in the Stocks Section
Navigate to the stocks market section and search for AZN. You can trade AstraZeneca PLC as a CFD with up to 1000x leverage.
- ✓Search for "AZN" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade AstraZeneca PLC.
- ✓Long (buy) if you expect AZN to rise
- ✓Short (sell) if you expect AZN to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
Ready to Trade AstraZeneca PLC?
Start trading AZN with up to 1000x leverage and zero fees.
Start Trading AZNTags
Frequently Asked Questions
AstraZeneca PLC is a stocks instrument available for trading on CoinUnited.io.
Disclaimers & References
Important Risk Disclaimer
All AstraZeneca PLC price predictions and forecasts presented on this platform are purely for informational and educational purposes. They do not constitute financial advice, investment recommendations, or guidance of any kind.
Cryptocurrency markets are highly volatile and unpredictable. Past performance is not indicative of future results. The predictions shown are based on mathematical models, historical data analysis, and various technical indicators, but cannot account for unforeseen market events, regulatory changes, or other external factors.
Users should conduct their own research and consult with qualified financial professionals before making any investment decisions. The creators and operators of this platform assume no responsibility for any financial losses or other damages that may result from reliance on the information provided.
Investing in cryptocurrencies involves substantial risk, including the possible loss of the entire investment amount.
Methodology Overview
Our AstraZeneca PLC price predictions utilize a multi-factor approach combining:
- Technical analysis (moving averages, oscillators, chart patterns)
- Machine learning models (LSTM networks, regression models)
- On-chain metrics (transaction volume, active addresses, exchange flows)
- Sentiment analysis (social media, news, crowd psychology)
- Macro factors (inflation, interest rates, correlation with traditional markets)
Last methodology review:
Ready to Start Trading AstraZeneca PLC?
Join thousands of traders and start your AstraZeneca PLC trading journey today. Get access to advanced trading tools and competitive fees.
AZN
AstraZeneca PLC
Live from CoinUnited.io